Abstract ErbB2 overexpression gives rise to a highly invasive, aggressive phenotype associated with an enlarged lysosomal compartment and increased activity of the lysosomal proteases, cysteine cathepsins. We have recent

First Page		Document Content
Date: 2016-03-02 01:55:24 Tyrosine kinase receptors Peptidase Clinical medicine Cancer Medicine Oncogenes Tyrosine kinases HER2/neu Cathepsin B Epidermal growth factor receptor ErbB Cathepsin Z		Abstract ErbB2 overexpression gives rise to a highly invasive, aggressive phenotype associated with an enlarged lysosomal compartment and increased activity of the lysosomal proteases, cysteine cathepsins. We have recent Add to Reading List Source URL: www.cancer.dk Download Document from Source Website File Size: 88,02 KB Share Document on Facebook

	Abstract ErbB2 overexpression gives rise to a highly invasive, aggressive phenotype associated with an enlarged lysosomal compartment and increased activity of the lysosomal proteases, cysteine cathepsins. We have recent DocID: 1rdcC - View Document
	Microsoft PowerPoint - SurfingPipeline_SLA_08June.ppt DocID: 1miSl - View Document
	Creamer et al. BMC Systems Biology 2012, 6:107 http://www.biomedcentral.comMETHODOLOGY ARTICLE Open Access DocID: 1mfK6 - View Document
	Supplementary Data Table S1: List of oncoproteins analyzed by Proseek Assay with Limit of Detection (LOD) in pg/ ml, working range (Lower Limit of Quantification, LLOQ, Upper Limit of Quantification, ULOQ) Olink Abbrevi DocID: 1apes - View Document
	ErbB/HER protein-tyrosine kinases: Structures and small molecule inhibitors DocID: 18Tu0 - View Document